)
Sarah Sterlace
Sr. Director, Portfolio Management, Neurobiology and Rare Disease,
Taconic Biosciences
Sarah Sterlace joined Taconic in 2024 and is currently Senior Director of Portfolio Management focusing on Neurobiology and Rare Disease. Sarah has more than 15 years of experience in drug discovery and life sciences support with an emphasis in emerging technologies and customer-focused solutions for advancing translational research.